$4.030
-0.069 (-1.71%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KLRS Prediction & Forecast by Similar Chart Analysis
Alphio's KLRS stock price prediction model matches the current Kalaris Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.94 (-2.22%). The 1-week path is $3.88 (-3.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Kalaris Therapeutics Inc Stock?
Kalaris Therapeutics is a good buy right now due to its recent positive clinical trial results for TH103, which showed significant improvements in vision and retinal anatomy, indicating strong potential for future growth. The stock is currently priced at $4.03, significantly lower than analyst targets of $17 and $25, suggesting a substantial upside potential. Additionally, the RSI is at 44.112, indicating the stock is not overbought, and the recent appointment of a new CFO may help stabilize the company's financial performance. However, the main risk is the ongoing negative net income, with losses reaching -11,515,000 USD in Q2 2026, which investors should monitor closely.
KLRS stock price ended at $4.03 on Friday, after losing -1.71%
Kalaris Therapeutics Inc (KLRS) last closed at $4.03, losing -1.71%. These facts feed the 1-day and 1-week KLRS price prediction above.
Forecast Drivers
Kalaris Therapeutics Inc (KLRS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches KLRS, ranked by similarity.
Seasonality analysis for KLRS
Historically the probability of a positive August return for KLRS is 34.92%. February offers the highest probability of a positive month at 58.62%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for KLRS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.35 | $2.40 | $2.53 | -40.37% |
| Sep 2026 | $2.25 | $2.49 | $2.87 | -38.32% |
| Oct 2026 | $2.01 | $2.17 | $2.37 | -46.15% |
| Nov 2026 | $1.85 | $2.13 | $2.37 | -47.07% |
| Dec 2026 | $2.37 | $2.42 | $2.74 | -39.92% |
In 2026, Kalaris Therapeutics Inc (KLRS) is projected to range from $1.85 to $2.87.
Kalaris Therapeutics Inc 2026 monthly forecast
In Aug 2026, Kalaris Therapeutics Inc is projected to average $2.40, with a low of $2.35 and high of $2.53.
In Sep 2026, Kalaris Therapeutics Inc is projected to average $2.49, with a low of $2.25 and high of $2.87.
In Oct 2026, Kalaris Therapeutics Inc is projected to average $2.17, with a low of $2.01 and high of $2.37.
In Nov 2026, Kalaris Therapeutics Inc is projected to average $2.13, with a low of $1.85 and high of $2.37.
In Dec 2026, Kalaris Therapeutics Inc is projected to average $2.42, with a low of $2.37 and high of $2.74.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.